Concepedia

Sonnet J.H. Arlander

SJ

Statistics

Publications

8

Citations

637

H-Index

8

Active since

2003

Affiliations

Mayo Clinic(Current)

Mayo Clinic in Arizona

Columbia University

Sonnet J.H. Arlander is an author at Mayo Clinic specializing in cell-cycle checkpoints, life sciences, and oncology.

Publications per year

2003–2010

8

Publications

8

Hsp90 Inhibition Depletes Chk1 and Sensitizes Tumor Cells to Replication Stress

Sonnet J.H. Arlander, Alex Eapen, Benjamin T. Vroman et al. · Journal of Biological Chemistry · 2003 · 171 citations · Full text

, , +17

Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival

Larry M. Karnitz, Karen S. Flatten, Jill M. Wagner et al. · Molecular Pharmacology · 2005 · 137 citations

, , +17

Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine

Ruben A. Mesa, David A. Loegering, Heather L. Powell et al. · Blood · 2005 · 115 citations · Full text

, , +11

Chaperoning Checkpoint Kinase 1 (Chk1), an Hsp90 Client, with Purified Chaperones

Sonnet J.H. Arlander, Sara J. Felts, Jill M. Wagner et al. · Journal of Biological Chemistry · 2005 · 92 citations · Full text

, , +16

Rad9 Protects Cells from Topoisomerase Poison-induced Cell Death

David A. Loegering, Sonnet J.H. Arlander, Jennifer S. Hackbarth et al. · Journal of Biological Chemistry · 2004 · 43 citations · Full text

, , +17

1–5 of 8